Wuhan Wuyao Pharmaceutical Co., Ltd., Huangshi, China – FDA Inspections

Inspection records and compliance data for Wuhan Wuyao Pharmaceutical Co., Ltd. in Huangshi. 3 FDA inspections on record, 1 Form 483, last inspected March 07, 2025.

Company Profile

This profile covers Wuhan Wuyao Pharmaceutical Co., Ltd. based in Huangshi, China.

FDA Inspection History

FDA inspections: 3
OAI: 0
VAI: 1
NAI: 1
Unclassified: 1
Form 483s: 1
Warning letters: 0

First inspected May 13, 2016. Last inspected March 7, 2025.

FDA inspections (3)

Date	Result	FDA center(s)	Insp. #
March 7, 2025	Not classified	Human Drugs	1265191
March 9, 2018	NAI	Human Drugs · Drug Quality Assurance	1050824
May 13, 2016	VAI	Human Drugs · Drug Quality Assurance	972877

FDA documents

No Form 483s, Warning Letters or EIRs on record.

Related Companies (10)

Companies with similar regulatory profiles, compliance history, and operations.

Jiangsu Yutian Pharmaceutical Co., Ltd.

Zhejiang Liaoyuan Pharmaceutical Co., Ltd.

Hefei Lifeon Pharmaceutical Co., Ltd. (API branch)

Zhejiang Chempacific Corporation

Maanshan Cosmos Chemical Co., Ltd.

Shenzhou Jiheng Pharmaceutical Co., Ltd.

Qinhuangdao Zizhu Pharmaceutical Co., Ltd.

Shanghai Desano Chemical Pharmaceutical Co., Ltd.

Shanghai Haoyuan Chemexpress Co., Ltd.

Betta Pharmaceuticals Co., Ltd.-Site C